Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 27 Issue 5
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2009  >  27(5): 357-358

XU Li, LI Chun-long, FANG fei-bo. Studies on cefazolin sodium pentahydrate in the treatment of COPD[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 357-358.
Citation: XU Li, LI Chun-long, FANG fei-bo. Studies on cefazolin sodium pentahydrate in the treatment of COPD[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 357-358.
shu

Studies on cefazolin sodium pentahydrate in the treatment of COPD

  • Department of pharmacy, 113th Hospial of PLA, Ningbo 315040, China

  • Received Date: 2009-03-26
  • Objective :To evaluate the efficacy and safety of cefazolin sodium pentahydrate in the treatment of acute stage of COPD. Methods : A randomized,controlled clinical trail was carried.A total of 65 patients of COPD were randomly divided into three groups(trial:25 cases,controlⅠ21 cases,controlⅡ19 cases),were administered intravenously at a dose of 2 g,bid,for 7 to 14 days. Results :At the end of the treatment,the cure rate and effective rate of three group were 80.00%(trial),71.43%(controlⅠ),47.37%(controlⅡ) amd 92.00%(trial),85.71%(controlⅠ),63.16%(controlⅡ) respectively.The incidence of adverse drug reaction were 4.00%,4.76%,5.26% respectively. Conclusion : The cefazolin sodium pentahydrate had an excellent clinical efficacy and good safety in treating patients with CODP.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2180) PDF downloads(545) Cited by()

Related
Proportional views

Studies on cefazolin sodium pentahydrate in the treatment of COPD

  • Department of pharmacy, 113th Hospial of PLA, Ningbo 315040, China
  • Received Date: 2009-03-26

Abstract: Objective :To evaluate the efficacy and safety of cefazolin sodium pentahydrate in the treatment of acute stage of COPD. Methods : A randomized,controlled clinical trail was carried.A total of 65 patients of COPD were randomly divided into three groups(trial:25 cases,controlⅠ21 cases,controlⅡ19 cases),were administered intravenously at a dose of 2 g,bid,for 7 to 14 days. Results :At the end of the treatment,the cure rate and effective rate of three group were 80.00%(trial),71.43%(controlⅠ),47.37%(controlⅡ) amd 92.00%(trial),85.71%(controlⅠ),63.16%(controlⅡ) respectively.The incidence of adverse drug reaction were 4.00%,4.76%,5.26% respectively. Conclusion : The cefazolin sodium pentahydrate had an excellent clinical efficacy and good safety in treating patients with CODP.

XU Li, LI Chun-long, FANG fei-bo. Studies on cefazolin sodium pentahydrate in the treatment of COPD[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 357-358.
Citation: XU Li, LI Chun-long, FANG fei-bo. Studies on cefazolin sodium pentahydrate in the treatment of COPD[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 357-358.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return